Saturday, May 21, 2022
No Result
View All Result
Medical Finance
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
No Result
View All Result
Medical Finance
No Result
View All Result
Home News

Pathogen works with drug to clear fungal infection, study shows

by Medical Finance
in News
New approach using RNA therapeutic can fix protein problems in cystic fibrosis
9
SHARES
99
VIEWS
Share on FacebookShare on Twitter

Pathogens don’t always work against drug treatments. Sometimes, they can strengthen them, according to a new University of Maine study.

Diseases caused by a combination of bacteria, viruses, fungi and parasites -; also known as polymicrobial infections -; are challenging to treat because scientists don’t fully understand how pathogens interact during infection and how these interactions impact the drugs used to treat them.

In a study published in the journal Infection and Immunity, researchers in the Molecular & Biomedical Sciences Department looked at two pathogens that often occur at similar sites, particularly in cystic fibrosis and mechanically ventilated patients: Candida albicans and Pseudomonas aeruginosa.

Candida is the fourth most common hospital-acquired pathogen, and is particularly difficult to treat. It is targeted by a number of antifungal agents, but some only slow it rather than kill it outright. Meanwhile, P. aeruginosa infects 90% of all adult cystic fibrosis patients. Combined, C. albicans and P. aeruginosa cause more serious disease in cystic fibrosis and ventilated patients.

The researchers investigated the effectiveness of an antifungal drug, fluconazole, in the test tube and during infection of the zebrafish with both pathogens. Fluconazole is known to slow fungal growth, but Candida can become tolerant to the drug and not only survive, but also develop tolerance that leads to failed therapy and, potentially, death.

What the study found was promising. The results showed that P. aeruginosa works with fluconazole to eliminate drug tolerance and clear the C. albicans infection in the culture and the zebrafish.

“Polymicrobial infections are challenging to treat not only because of the lack of understanding of how invading microorganisms interact but also because we don’t know how these interactions affect treatment efficacy. Our work demonstrates that polymicrobial interactions can indeed affect treatment efficacy and, most importantly, it highlights the importance of nutrient availability in the environment -; such as iron in our study -; and how it modulates treatment efficacy,” says Siham Hattab, lead author of the study who conducted the research as part of her Ph.D. in the Department of Molecular and Biomolecular Sciences.

What’s more, the bacteria also enhance the drug’s ability against a second pathogenic Candida species that tends to be more resistant to the drug.

The increased effectiveness of the drug suggests to the researchers that there is still much more to learn about how current drugs work when targeting these dangerous and complex polymicrobial infections.

We are really excited to have revealed that sometimes drugs against fungal infection can work even better in a more ‘real-world’ situation than in the test tube. There is still a lot to learn about how pathogens interact during infection, and it will be interesting to see how the bacteria manage to work with the drugs to target Candida.“


Robert Wheeler, associate professor of microbiology and senior author of the study

Source:

Journal reference:

Hattab, S., et al. (2022) Pseudomonas Synergizes with Fluconazole against Candida during Treatment of Polymicrobial Infection. Infection and Immunity. doi.org/10.1128/iai.00626-21.

Total
0
Shares
Share 0
Tweet 0
Pin it 0
Share 0
Medical Finance

Medical Finance

Related Posts

KHN’s ‘What the Health?’: FDA takes center stage

Intranasal delivery of pro-resolving lipid mediators arrests memory loss in experimental Alzheimer’s model

by Medical Finance
May 21, 2022
0

A research collaboration between scientists at LSU Health New Orleans and the Karolinska Institutet in Sweden has found that applying...

RNA-chopping enzyme Dicer stabilizes mammalian chromosomes with the help of BRD4 activator

COVID-19 mortality among elderly may be due to genetically predetermined limit on the immune system

by Medical Finance
May 20, 2022
0

Your immune system's ability to combat COVID-19, like any infection, largely depends on its ability to replicate the immune cells...

Blocking an enzyme activity inside fat cells can reduce obesity in mice

Blocking an enzyme activity inside fat cells can reduce obesity in mice

by Medical Finance
May 20, 2022
0

Blocking the activity of an enzyme inside fat cells can decrease obesity and related health disorders in mice, according to...

Study: Significance of the RBD mutations in the SARS-CoV-2 Omicron: from spike opening to antibody escape and cell attachment. Image Credit: Fit Ztudio/Shutterstock

Omicron RBD mutations increase ACE2 binding and reduce antibody sensitivity

by Medical Finance
May 20, 2022
0

In a study conducted at the Florida International University, USA, scientists have investigated the impact of spike receptor-binding domain (RBD)...

ANU researchers identify why Th17 cells go rogue and promote the onset of multiple sclerosis

ANU researchers identify why Th17 cells go rogue and promote the onset of multiple sclerosis

by Medical Finance
May 21, 2022
0

Researchers from The Australian National University (ANU) have identified why certain cells in the body, known as Th17 cells, go...

Research provides a comprehensive map of exercise-induced signaling molecules present in the tissues

Research provides a comprehensive map of exercise-induced signaling molecules present in the tissues

by Medical Finance
May 20, 2022
0

It is well established that exercise improves health, and recent research has shown that exercise benefits the body in different...

Next Post
Study: SARS-CoV-2 Infections in Professional Orchestra and Choir Musicians – A Prospective Cohort Study. Image Credit: Skreidzeleu/Shutterstock

Incidence of SARS-CoV-2 infections in orchestra and choir musicians

Study: NRP1 and furin as putative mediators of SARS-CoV-2 entry into human brain cells. Image Credit: Kateryna Kon/Shutterstock

Researchers discover mechanism behind SARS-CoV-2 entry into the brain

0 0 votes
Article Rating
Subscribe
Login
Notify of
guest
guest
0 Comments
Inline Feedbacks
View all comments

Support

  • Contact
  • Disclaimer
  • Home
  • Privacy Policy
  • Terms And Conditions

Categories

  • Coronavirus
  • Insights From Industry
  • Interviews
  • Mediknowledge
  • News
  • Thought Leaders
  • Whitepapers

More News

  • Study: Epidemiologic Assessment of Pediatric Inflammatory Bowel Disease Presentation in NYC During COVID-19. Image Credit: JARIRIYAWAT/Shutterstock
    Association between the COVID-19 pandemic and inflammatory bowel disease presentation in New York City
  • Study: Immune response to third SARS-CoV-2 vaccination in seronegative kidney transplant recipients: possible improvement by mycophenolate mofetil reduction. Image Credit: NIAID
    Response to COVID-19 vaccine booster in seronegative kidney transplant recipients
  • Home
  • Privacy Policy
  • Contact
  • Disclaimer
  • Terms And Conditions

© 2022 Medical Finance - Latest Financial and Business News

No Result
View All Result
  • Interviews
  • Mediknowledge
  • News
  • Insights From Industry
  • Coronavirus
  • Thought Leaders
  • Whitepapers
wpDiscuz
0
0
Would love your thoughts, please comment.x
()
x
| Reply